News | Ventricular Assist Devices (VAD) | October 05, 2015

Catheter-Based Heart Failure Pump Wins Innovative Technology Design Competition

Six-cm device features powerful micro-pump to rest and heal the heart without surgery
 

Procyrion, Aortix device, grand prize, Create the Future Design Contest

October 5, 2015 — Procyrion Inc. of Houston has been awarded the grand prize of $20,000 in the 2015 "Create the Future" Design Contest for the first catheter-deployed heart pump intended for long-term treatment of chronic heart failure. The Aortix device — thinner than a No. 2 pencil and only 6 cm long — features a powerful micro-pump designed to rest and heal the heart without surgery and with minimal risk.

Aortix was among the record 1,159 new product ideas submitted in the 13th annual design contest, which was established in 2002 to recognize and reward engineering innovations that benefit humanity, the environment and the economy. This year's design contest was co-sponsored by COMSOL and Mouser Electronics. Analog Devices and Intel were supporting sponsors.

In addition to the grand prize of $20,000, first-place winners were named in seven categories in various industries. In the medical field Smart X-ray Source won for combining flat panel X-ray detector technology with classic X-ray physics to provide portable, inexpensive computed tomography (CT) systems using open software sources to underserved populations around the world.

Finalists were selected by senior editors at Tech Briefs Media Group and judged by an independent panel of design engineers. Visitors to the contest website could vote on entries, with the 10 most popular designs awarded an Ollie robotic gaming device provided by Sphero.

For more information: www.createthefuturecontest.com


Related Content

Feature | Heart Failure | Kyle Hardner

Editor's Note: This is Part Three of a three-part series highlighting several of the presentations from the American ...

Home May 13, 2026
Home
News | Heart Failure

May 10, 2026 — Results from the first randomized trial evaluating microRNA inhibition in heart failure were presented ...

Home May 11, 2026
Home
Feature | Heart Failure | Kyle Hardner

Could a link between the heart, brain and immune system help reduce the occurrence of heart attacks and lessen the ...

Home May 04, 2026
Home
News | Heart Failure

April 21, 2026 — Nuwellis, Inc. has announced a software update to its Aquadex SmartFlow ultrafiltration platform. The ...

Home April 23, 2026
Home
News | Heart Failure

March 28, 2026 — Amgen announced today that Repatha (evolocumab), when added to statins or other low-density lipoprotein ...

Home April 06, 2026
Home
News | Heart Failure

March 24, 2026 — New research shows that small improvements to sleep, diet quality and physical activity, made in ...

Home March 25, 2026
Home
News | Heart Failure

March 16, 2026 — Cytokinetics has announced four presentations related to Myqorzo (aficamten) at the American College of ...

Home March 16, 2026
Home
Feature | Heart Failure | Rohit Sood, MD, PhD

Cardiovascular disease (CVD) is a serious global health burden that encompasses a broad group of diseases that affect ...

Home February 12, 2026
Home
News | Heart Failure

Feb. 3, 2026 — Bristol Myers Squibb has launched "Change the Target. Change What’s Possible," an educational campaign ...

Home February 03, 2026
Home
News | Heart Failure

Jan. 27, 2026 — A new national study reveals a stark disconnect between Americans’ desire for preventive cardiac ...

Home January 27, 2026
Home
Subscribe Now